Hyperlipidemia News and Research

RSS

Hyperlipidemia, hyperlipoproteinemia or dyslipidemia is the presence of raised or abnormal levels of lipids and/or lipoproteins in the blood. Lipids (fatty molecules) are transported in a protein capsule, and the density of the lipids and type of protein determines the fate of the particle and its influence on metabolism.

Facial temperature can predict heart disease with higher accuracy than current methods

Researchers found that facial infrared thermography can predict coronary artery disease more accurately than traditional pretest probability tools, using deep-learning algorithms to analyze temperature patterns.

6 Jun 2024

Garlic proves potent in reducing blood sugar and cholesterol, study reveals

Study confirms garlic's significant benefits in lowering blood glucose and lipid levels, offering a natural remedy for metabolic disorders.

2 Jun 2024

Type 2 diabetes linked to higher cancer risk, especially with diabetic retinopathy, study finds

A recent study in BMC Medicine found that type 2 diabetes significantly increases the risk of various cancers, with the risk being even higher in patients with diabetic retinopathy (DR).

2 Jun 2024

COVID-19 associated with higher risk of erectile dysfunction

Men previously diagnosed with COVID-19 are at a greater risk of developing new-onset erectile dysfunction.

31 May 2024

RNA interference agent plozasiran targets APOC3 for effective mixed hyperlipidemia treatment

Researchers evaluate the efficacy of plazosiran treatment on fasting triglyceride levels in adult patients with mixed hyperlipidemia.

31 May 2024

RNA-based therapy shows promise in reducing cholesterol and triglycerides

A small interfering RNA (siRNA) investigational therapy that inhibits a gene involved in lipoprotein metabolism has been shown in a clinical trial led by Mount Sinai researchers to significantly reduce levels of different types of cholesterol and triglycerides in individuals with mixed hyperlipidemia, a condition in which fats build up in the blood.

29 May 2024

Increased risk of erectile dysfunction with semaglutide in non-diabetic obese patients

Researchers found that semaglutide treatment for weight loss in non-diabetic, obese men is associated with an increased risk of erectile dysfunction and testosterone deficiency.

26 May 2024

Anti-obesity medications slash heart disease risk in obese patients, study finds

A study in the journal Obesity evaluated the impact of new anti-obesity medications (AOMs) on cardiovascular disease (CVD) among obese individuals, finding that these medications reduce the risk of CVD complications, particularly heart failure and atrial fibrillation.

15 May 2024

Metabolomic analysis sheds light on gut microbes' role in cardiovascular disease risk

The effect of gut bacteria on non-high-density lipoprotein cholesterol (non-HDL-c) variations.

14 May 2024

New study shows age, sex, race crucial for predicting mortality risks in older adults

Study finds that the LS7 and LE8 scores predict all-cause and cardiovascular mortality with similar efficacy in the overall U.S. population. However, the PCE score is better at predicting mortality in individuals aged 40 to 79.

5 May 2024

Cinnamon, curcumin, and resveratrol show promise in diabetes inflammation fight

Researchers reviewed the impact of cinnamon, curcumin, and resveratrol on oxidative stress and inflammation in type 2 diabetes patients, highlighting their potential to improve metabolic regulation and reduce complications.

26 Apr 2024

Linking lifestyle to longevity: How diet and hypertension sway risks for heart disease and cancer

Study reviews epidemiological evidence linking modifiable risk factors like diet and hypertension to both cardiovascular disease (CVD) and cancer, suggesting a shared pathophysiology and potential strategies for simultaneous prevention and management.

11 Apr 2024

Hyperlipidemia News and Research

Further Reading

Facial temperature can predict heart disease with higher accuracy than current methods

Garlic proves potent in reducing blood sugar and cholesterol, study reveals

Type 2 diabetes linked to higher cancer risk, especially with diabetic retinopathy, study finds

COVID-19 associated with higher risk of erectile dysfunction

RNA interference agent plozasiran targets APOC3 for effective mixed hyperlipidemia treatment

RNA-based therapy shows promise in reducing cholesterol and triglycerides

Increased risk of erectile dysfunction with semaglutide in non-diabetic obese patients

Anti-obesity medications slash heart disease risk in obese patients, study finds

Metabolomic analysis sheds light on gut microbes' role in cardiovascular disease risk

New study shows age, sex, race crucial for predicting mortality risks in older adults

Cinnamon, curcumin, and resveratrol show promise in diabetes inflammation fight

Linking lifestyle to longevity: How diet and hypertension sway risks for heart disease and cancer

Infertile men more likely to have impaired kidney function, study says

Exploring the role of iodine in obesity, diabetes, and other metabolic conditions

Age-related changes in the shape of brain neurons lead to middle-age obesity

Link between nutrient intake and multimorbidity risk reported in recent study, more research is needed

Eating live microbe-rich foods linked to better heart health

The impact of quinoa bioactive compounds on gut health

Spirulina shows promise in battling heart disease and diabetes

Flavonol-rich diet linked to lower mortality and disease risk, study shows

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News